Valiant Laboratories Ltd
VALIANTLAB
Company Profile
Business description
Valiant Laboratories Ltd is an Active Pharmaceutical Ingredient (API)/Bulk Drug manufacturing company with having focus on manufacturing Paracetamol. Paracetamol is one of the widely used analgesics globally and is recommended as the first-line therapy in pain conditions by the World Health Organization. Paracetamol has several applications such as usage in the treatment of headaches, muscle aches, arthritis, backaches, toothaches, colds, and fever. It manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.
Contact
Mulund Goregaon Link Road
104, Udyog Kshetra
MulundMH400080
INDT: +91 2249712001
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
77
Stocks News & Analysis
stocks
We take a different view to market on ASX bloodbath
Sales growth at CSL was lower than expected but streamlining the business has its perks.
stocks
BHP earnings weaker with lower iron ore prices more than offsetting higher copper volumes
Results were softer than expected.
stocks
Moated ASX player makes moves to support growth in China
a2Milk announced an acquisition and a divestiture as it aims to take a bigger slice of China’s baby formula market.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,177.40 | 3.60 | 0.04% |
CAC 40 | 7,937.75 | 41.33 | -0.52% |
DAX 40 | 24,228.99 | 194.08 | -0.79% |
Dow JONES (US) | 44,922.27 | 10.45 | 0.02% |
FTSE 100 | 9,176.11 | 13.11 | -0.14% |
HKSE | 25,191.58 | 68.68 | 0.27% |
NASDAQ | 21,314.95 | 314.82 | -1.46% |
Nikkei 225 | 42,888.55 | 657.74 | -1.51% |
NZX 50 Index | 13,071.30 | 142.62 | 1.10% |
S&P 500 | 6,411.37 | 37.78 | -0.59% |
S&P/ASX 200 | 8,918.00 | 21.80 | 0.25% |
SSE Composite Index | 3,766.21 | 38.92 | 1.04% |